Sutro Biopharma Stock Options Expiring on 19th of September
| STRO Stock | USD 0.85 0.01 0.65% |
Sutro Biopharma's latest option contracts expiring on September 19th 2025 are carrying combined implied volatility of 3.75. The Sutro Biopharma option chain provides detailed quote and price information for the current Sutro Biopharma option contracts. It shows all of Sutro Biopharma's listed puts, calls, expiration dates, strike prices, and other pricing information.
Please note that buying 'in-the-money' options on Sutro Biopharma lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Sutro Biopharma's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Sutro Biopharma contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Sutro Stock moves the wrong way.
Sutro Biopharma In The Money Call Balance
When Sutro Biopharma's strike price is surpassing the current stock price, the option contract against Sutro Biopharma stock is said to be in the money. When it comes to buying Sutro Biopharma's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Sutro Biopharma are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Sutro Current Options Market Mood
Sutro Biopharma's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Sutro Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Unfortunately, most Sutro Biopharma's options investors are not very successful. Sutro Biopharma's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Sutro contract
Base on the Rule 16, the options market is currently suggesting that Sutro Biopharma will have an average daily up or down price movement of about 0.23% per day over the life of the 2025-09-19 option contract. With Sutro Biopharma trading at USD 0.8544, that is roughly USD 0.002003. If you think that the market is fully incorporating Sutro Biopharma's daily price movement you should consider buying Sutro Biopharma options at the current volatility level of 3.75%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Sutro Biopharma Option Chain
When Sutro Biopharma's strike price is surpassing the current stock price, the option contract against Sutro Biopharma stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Sutro Biopharma's option chain is a display of a range of information that helps investors for ways to trade options on Sutro. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Sutro. It also shows strike prices and maturity days for a Sutro Biopharma against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | STRO250919C00007500 | 0 | 7.5 | 0.0 - 0.75 | 0.75 | |
Call | STRO250919C00005000 | 0 | 5.0 | 0.0 - 0.75 | 0.75 | |
Call | STRO250919C00002500 | 0 | 2.5 | 0.0 - 0.75 | 0.75 | |
Call | STRO250919C00002000 | 0 | 2.0 | 0.0 - 1.0 | 1.0 | |
Call | STRO250919C00001500 | 0 | 1.5 | 0.0 - 0.75 | 0.75 | |
Call | STRO250919C00001000 | 0 | 1.0 | 0.0 - 0.25 | 0.25 | |
Call | STRO250919C00000500 | 0 | 0.5 | 0.05 - 1.05 | 0.05 | In |
Put | STRO250919P00007500 | 0 | 7.5 | 4.2 - 8.8 | 4.2 | In |
Put | STRO250919P00005000 | 0 | 5.0 | 1.75 - 6.2 | 1.75 | In |
Put | STRO250919P00002500 | 0 | 2.5 | 0.0 - 4.5 | 4.5 | In |
Put | STRO250919P00002000 | 0 | 2.0 | 0.65 - 1.6 | 0.65 | In |
Put | STRO250919P00001500 | 0 | 1.5 | 0.05 - 1.05 | 0.05 | In |
Put | STRO250919P00001000 | 0 | 1.0 | 0.0 - 0.3 | 0.3 | In |
Put | STRO250919P00000500 | 0 | 0.5 | 0.0 - 0.75 | 0.75 |
Sutro Biopharma Market Cap Over Time
Market Cap |
| Timeline |
Sutro Total Stockholder Equity
Total Stockholder Equity |
|
Sutro Biopharma Corporate Management
| Barbara Leyman | Chief Officer | Profile | |
| Shabbir Anik | Chief Technical Operations Officer | Profile | |
| William JD | CEO Director | Profile | |
| Nicki Vasquez | Chief Officer | Profile | |
| BA CPA | Chief Officer | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sutro Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Sutro Stock, please use our How to Invest in Sutro Biopharma guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sutro Biopharma. If investors know Sutro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sutro Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.92) | Revenue Per Share | Quarterly Revenue Growth 0.338 | Return On Assets | Return On Equity |
The market value of Sutro Biopharma is measured differently than its book value, which is the value of Sutro that is recorded on the company's balance sheet. Investors also form their own opinion of Sutro Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Sutro Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sutro Biopharma's market value can be influenced by many factors that don't directly affect Sutro Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sutro Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sutro Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sutro Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.